Vascular plugs – A key companion to Interventionists – ‘Just Plug it’  by Ramakrishnan, Sivasubramanian
ww.sciencedirect.com
i n d i a n h e a r t j o u rn a l 6 7 ( 2 0 1 5 ) 3 9 9e4 0 5Available online at wScienceDirect
journal homepage: www.elsevier .com/locate/ ih jC3 - Core Curriculum in CardiologyVascular plugs e A key companion to
Interventionists e ‘Just Plug it’Sivasubramanian Ramakrishnan*
Additional Professor, Department of Cardiology, All India Institute of Medical Sciences, Delhi, Indiaa r t i c l e i n f o
Article history:
Received 2 July 2015
Accepted 2 July 2015





Occlusion* Department of Cardiology, Room No. 10
26594420; fax: þ91 11 26588663.
E-mail address: ramaaiims@gmail.com.
http://dx.doi.org/10.1016/j.ihj.2015.07.001
0019-4832/Copyright © 2015, Cardiological Sa b s t r a c t
Vascular plugs are ideally suited to close extra-cardiac, high flowing vascular communi-
cations. The family of vascular plugs has expanded. Vascular plugs in general have a lower
profile and the newer variants can be delivered even through a diagnostic catheter. These
features make them versatile and easy to use. The Amplatzer vascular plugs are also used
for closing intracardiac defects including coronary arterio-venous fistula and paravalvular
leakage in an off-label fashion. In this review, the features of currently available vascular
plugs are reviewed along with tips and tricks of using them in the cardiac catheterization
laboratory.
Copyright © 2015, Cardiological Society of India. All rights reserved.1. Introduction
Closure of abnormal natural or artificial vascular communica-
tions is frequently performed in the catheterization laboratory.
Commonly, 2 types ofmaterials are used for closure of vascular
communications,which includematerials for embolization like
coils, gel foam or particles and the various septal/duct occlud-
ers. Embolizationmaterials like coils are relatively inexpensive,
have a low profile and are easy to deliver; but the release of
these materials cannot be secure and the rates of embolism is
higher. The occluder devices are expensive, need a relatively
larger sheath for delivery and are difficult to deliver in tortuous
structures due to their bulkier profiles. However, the duct/
septal occluders can be released in a controlled fashion. The
vascular plugs have features of both embolic materials and
occluderdevices.Theyhavea relatively lowerprofileand canbe
released in a controlled fashion. Almost all the published, 8th Floor, All India Inst
ociety of India. All rightsliterature with the vascular plugs is with Amplatzer vascular
plugs (AVP) [St. Jude Medical, Inc.; Minnesota, USA].1e5 AVP
have evolved over years and are available in four different
forms now e AVP IeAVP IV. All these forms of AVPs have been
used for the embolization of medium to large vascular com-
munications. Recently, Cera™ series of plugs from Lifetech
[Lifetech Scientific Corp., China] became available.6 Cardiac
plugs for the closure of left atrial appendage andmicroplugs are
the latest additions7,8 to the series of vascular plugs. In this
article, the various forms of plugs and technical aspects of their
use in cardiac catheterization laboratory are reviewed.2. Types of vascular plugs
AVP are established embolic devicesmanufactured by St. Jude
Medical [St. Jude Medical, Inc.; St. Paul, Minnesota, USA]. Theitute of Medical Sciences, New Delhi 110029, India. Tel.: þ91 11
reserved.
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Administration) in May 2004, for peripheral vascular emboli-
zations. The indication for AVP and their usage have
expanded significantly. The AVP II was introduced in 2007. All
these plugs are self-expanding devices made of nitinol wire
mesh which can be cylinderlized into a sheath. Upon release
they assume the pre-specified shape due to the property of
thermal memory. The differences among the series of AVPs
are presented in Table 1 and Fig. 1. AVP I has single lobe and
AVP II has 3 lobes, whereas AVP III and IV are bilobed. AVP I
and IV are single layered, andAVP II and III aremultilayered.1,3
All these devices are complimentary additions and are not a
replacement of earlier version. Each of them has a unique
feature that is useful in a specific clinical situation.
The initial AVP, (also known as AVP I), made of finely
braidedNitinol wire, had a single-layermesh and a single-lobe
design. It has a high radial force and is ideal for structures
with short landing zone. However, choosing the appropriate
length and diameter of the device is very critical as there are
no rims on either side. AVP requires a longer time for complete
occlusion. The AVP II is designed to improve the occlusive
properties and has a finer and more densely woven nitinol
braided in two or 3 layers. It has a central lobe and 2 discs on
each side. The multi-layered, multi-segmented design re-
duces the time to occlusion and offers full cross-sectional
vessel coverage. Thus, AVP II has lower migration and
recanalization chances. The multi-layered mesh lobes create
six occlusive planes, which enable faster vessel occlusion.1,3
AVP III is designed for embolization of structureswith a very
high flow. AVP III has an oblong cross-sectional shape made of
multiple Nitinol mesh layers and has extended rims. It has the
fastest occlusion properties. Device rims extending beyond
device body enables full wall apposition and enhances stability
in high-flow vessels. AVP III fits elliptical shaped vascular
structures. AVP IV has the best profile among all the AVPs. In
fact AVP IV can be delivered through a 0.038 compatible diag-
nostic catheter (5F diagnostic catheters). This eliminates the
need for catheter exchange. Flexiblemesh and the floppy distal
section of the delivery wire make AVP IV attain a very low-
profile, which improves the reach to distal vasculature and
across tortuous and angulated structures. The multi-layered,
double-lobed design also enables rapid embolization. Howev-
er, AVP IV is only available up to a size of 8 mm.3
Cera™ is a new brand of plugs manufactured by Lifetech
[Lifetech Scientific Corp., China]. The manufacturers claimTable 1 e Device characteristics of various generations of vasc
AVP I AVP II AVP II
Structural details Single
lobe







4e16 3e22 Long axis, 4
Length of plug (mm) 7e8 6e18 Short axis,
Guide catheter (Fr) 5e8 5e9 6e9
Modified from Wang W, et al 2012.1
a Only useful for left atrial appendage (LAA) occlusion.that the Titanium Nitride (TiN) coating prevents thrombosis
and improves endothelialization. It has a single lobe and has
PTFEmaterial for faster occlusion. Initial clinical data on other
forms of this device is published recently.6
2.1. Amplatzer cardiac plug
The Amplatzer cardiac plug-2 (ACP 2) is a self-expanding de-
vice specifically designed for left atrial appendage (LAA)
closure. ACP 2 has a distal lobe along with a proximal disc
connected by a short waist. The ACP 2 is deployed through a
septal puncture using a transfemoral route.7
2.2. Micro plugs
The micro-plugs are latest addition to the plug family, which
can be delivered through a micro catheter. These micro plugs
are available in 3 mm and 5 mm sizes that enables super-
selective embolization of distal vessels.83. Indications for vascular plugs
Indications for the use of vascular plugs have expanded and it
is said that there are no contraindications.1 However, their use
is approved for extra-cardiac vascular structures only in some
countries. Most of the existing literature regarding vascular
plugs is with the AVP family and pertains to its use in pe-
ripheral vascular malformations. Excellent reviews are avail-
able that summarizes the use of AVP in closing peripheral
vascular structures ranging from arterial malformations, an-
eurysms, Arterio-Venous (AV) malformations, for venous oc-
clusion including portal vein embolization, and even endoleak
associated with EAVR. AVP have been used to occlude arteries
including internal iliac, carotid, splenic, renal and gastrodu-
odenal artery embolizations. They are also useful to close the
various man-made shunts including AV fistula for hemodial-
ysis, and transjugular intrahepatic portosystemic shunt (TIPS)
occlusion.1,9
The ease of use, lower profile and precise deliverability
make it ideally suited to close congenital malformations in
even smaller children. Recently, a few case series have
described the use of AVPs in various congenital malforma-
tions.3,10,11 Shwartz's et al, initially described the use of AVP I
and II in congenital heart disease, mostly in patients with PDAular plug family.
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Fig. 1 e Family of Amplatzer vascular plugs left panel shows the configuration of Type I to type IV e Amplatzer vascular
plugs (AVP) right upper panel shows the Cera™ vascular plug from Lifetech Corporation right lower panel shows the
Amplatzer Cardiac Plug (ACP) 2, which is designed for left atrial appendage occlusion.
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from India describing the use of AVP in various congenital
malformations.3,10 AVP may be considered the embolic ma-
terial of choice for closing coronary AV malformations, pul-
monary AV malformations, closure of BT (Blalock-Taussig)
shunt, occluding large aorto-pulmonary collaterals, arterio-
venous communications, surgically created fenestrations,
antegrade flow across the pulmonary valve following Glenn
shunt and veno-venous communications in a patient with
Fontan surgery. AVP seems to be ideally suited for the closure
of whatever extra-cardiac ‘extra’ vascular channel.
AVP is emerging as an alternative to surgery in patients
with a tubular PDA. A few small case series have described the
successful use of AVP II for small and moderate PDA.12,13 An
initial series4 described the use of AVP in 20 small children
with tubular PDA and documented complete occlusion in all
the patients. The authors used a mean plug to duct diameter
ratio of 1.46 ± 0.42. Recently, AVP IV has been successfully
used in closing tubular PDA. In a series of 47 patients,
including 39 infants, AVP IV alone was sufficient to achieve
complete closure of PDA in all except one patient who had late
embolization. They oversized the device by 1.9 ± 0.1mmmore
than themeasured vessel diameter.13 However, latemigration
of a successfully deployed AVP is reported in an adult patient
with PDA.14 Hence, the use of these devices for PDA should be
reserved for experienced operators. A few case reports have
also described the use of AVP for closing ruptured sinus of
Valsalva aneurysms.15
Another indication that seems to ideally require a plug is
transcatheter paravalvular leak closure. In most of the case
series an AVP III has been successfully used through either an
ante- or retrograde access for mitral and retrograde approach
for aortic paravalvular leaks. It is nearly successful in all pa-
tients with aortic paravalvular leak and is successful in 89.7%
patients with mitral paravalvular leak.16,174. Procedural details and tips for use
4.1. Choosing the correct type and size of AVP
The choice of AVP depends on vessel type to be embolized,
size of the vessel, quantum of blood flow, approach to the
intended site of occlusion and the available landing zone.
Fig. 2 highlights the ideal indications for different forms of
AVPs. In most of the series, AVP I was the most common type
used before AVP II became available for clinical use. Since AVP
II became available, it is the most commonly used plug due to
better and rapid occlusive properties and wide availability of
sizes. AVP I is still useful for vascular structures with short
landing zones. Type III is preferred formedium sized high flow
tubular/elliptical structures, where faster occlusion is desired.
Type III seems particularly suitable for closing the para-
valvular leaks. AVP IV is suitable for closing smaller structures
(<6 mm diameter) that have a tortuous or angulated course.
Deployment of different forms of AVPs in different clinical
scenarios is presented in Fig. 3.
We measure the most restrictive diameter along the
length of the vascular channel to be closed. It is recom-
mended that a device is chosen that is at least 30e50% larger
than the size of the native vessel. The mean device to vessel
ratio was 1.4e1.5 in most of the published series. For
instance, for a vessel size of 4 mm diameter, a plug with a
diameter of 6 mm, and for a vessel of 5 mm a plug with a
diameter of 8 mm is generally chosen. The length of the
vessel and the available landing zone is also an important
determinant of the plug size. An oversized AVP tend to
lengthen significantly across the vessel. Hence, a plug must
be chosen that is large enough to ensure complete occlusion,
but at the same time does not elongate and protrude into
nearby structures.
AVP  
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Fig. 2 e Choice of AVP The in vivo deployment shape of all forms of Amplatzer vascular plugs (AVP) is presented with their
salient features and important indications.
Fig. 3 e Examples of deployment of AVP IeIV The panel shows the configuration of AVP after deployment in various
vascular structures: (a). AVP type I across a modified Blalock Taussig (BT) shunt, (b). AVP II across a large aorto-pulmonary
collateral (APC), (c). AVP III across an APC and (d). AVP IV across an APC (Reproduced with permission from ref no 3).
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i n d i a n h e a r t j o u rn a l 6 7 ( 2 0 1 5 ) 3 9 9e4 0 5 4034.2. Procedural details
The procedure may be done under local anesthesia even in
infants. Commonly femoral arterial or venous route is
preferred as needed. However, the plug can be easily delivered
using jugular venous or unconventional routes if needed.18
We commonly use the Judkin's right (JR) guide catheter (Cor-
dis Corporation, Miami, FL, USA) 5e7F for most of the plug
delivery. The other catheters that are often useful depending
on the vascular anatomy include Multipurpose (MP),
Amplatzer duct occluder (ADO) delivery sheath (St Jude Inc,
MN, USA), Cook delivery sheaths (Cook, Bloomington, USA),
carotid shudder sheath, renal guide, Amplatz left (AL) and
Amplatz right (AR) guide catheters.
In most instances, a Judkin's right coronary, Picard or
Conard catheter is used to hook the vessel and cross the site
of interest using a J tipped Terumo wire (Terumo Medical
Corporation, Somerset, NJ, USA). An exchange length Terumo
or ordinary guidewire is advanced and is parked distally.
Then over that wire, a guide catheter of choice is taken across
the intended site of closure. It may be preferable to take a one
size larger bore catheter than recommended especially
across tortuous structures. In some instances, there could be
difficulty in adequately advancing the guide catheter. Then a
catheter in catheter (mother and child) technique may be
useful.19 At times we start with the catheter in catheter
system so that exchanging with a stiffer wire could be avoi-
ded. A 4F or 5F diagnostic catheter with sufficient length to
protrude outside a 6F or 7F guide catheter is taken along with
a Terumo wire. In most of the difficult situations, this tech-
nique commonly succeeds. At times de-airing becomes
difficult once the guide is placed distally. De airing is
extremely important when air embolism could lead to sys-
temic events like in pulmonary AV malformations. It may be
preferable to use a coronary Tohue Bosht system and deair
the system before advancing. The chosen AVP is taken and
deployed across the intended site using less traction on the
assembly. Due to its lower profile the device may beFig. 4 e Use of an AVP for closure of a pulmonary arterio-venou
large pulmonary AVmalformation from the left lower pulmonar
across the feeding vessel showing complete abolition of flow.recaptured and redeployed with ease if needed. A good
quality angiogram may be obtained with the same guide
catheter or additional diagnostic catheters. Once total oc-
clusion is demonstrated, AVP is released by unscrewing in
counter-clockwise rotation. Then a final angiogram is ob-
tained commonly after 10 min of deployment of AVP, when
most of the minor residual flow generally disappears. An
excellent example of a procedure that was simplified due to
the use of AVP, closure of a pulmonary AV malformation, is
presented in Fig. 4.5. Advantages of vascular plugs
Vascular plugs are ideal for embolization of medium to large
vessels with high flow. These vascular structures are often
closed using a single AVP that otherwise would have
required many coils. Thus, AVPs are efficient and a cost-
effective alternative to coils and other occlusion devices.
The family of AVP offers a wide flexibility to select the cor-
rect vascular plug for the type of vessel. Use of AVP reduces
the procedure times and results in low radiation exposure.
The lower profile of these devices enables a technically
simpler procedure. The technical success is achieved in
nearly all patients. The device visibility is excellent under
fluoroscopy with limited imaging artifacts. Screwing with a
delivery cable allows for precise delivery and secure posi-
tioning of AVP. Accurate placement even in large high-
flowing vascular structures can be readily achieved with
AVP as compared to coils. Hence, AVPs are associated with a
very low device embolism risk. Multi-layered Nitinol mesh
makes the plug faster to occlude and AVPs have a lower
recanalization rates. Thus, most of the properties of AVP
resemble that of duct/septal occluders. However, AVP has a
lower profile generally as compared to the same size of duct/
septal occluders. In our series also, AVP was successfully
deployed when occlusion with septal/duct occluder failed20
(Fig. 5).s (AV) malformation. (a). Pulmonary angiogram showing a
y artery. (b). Successful and precise deployment of an AVP 2
Fig. 5 e Successful use of an Amplatzer vascular plug (AVP) for closure of a Fontan fenestration, where septal/duct occluders
failed. (a). Angiogram showing baffle leak (arrow) following lateral tunnel Fontan leading to significant desturation. (b).
Initially, an veno-arterial loop was created, but the duct occluder sheath could not be advanced due to difficult angulation.
(c). An AVP I was successfully deployed across the baffle leak through jugular approach. (These figures were published in
Ref no. 20. Ramakrishnan S, Kothari SS, Singh N, Singh S. Baffle leak following lateral tunnel Fontanetreated with a vascular
plug. Indian Heart J 2009; 61:285e7. Copyright Cardiological society of India”).
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6.1. Technical success
The technical success could be achieved in most of the pa-
tients using an AVP. Various series have reported a technical
success rate of 92e100%. The variation is mostly due to the
definition of technical success.1e5
6.2. Residual flow
The rate of residual flow is variable depending on the time of
final angiogram. Demonstration of complete flow occlusion is
essential at the end of the procedure. An adequate oversizing
of the device, proper deployment, and better occlusion prop-
erties of newer plugs reduces the chance of residual flow.
However, the newer plugs have a variable time of occlusion. It
is reported that higher flow, large vessel size and coagulop-
athy are predictors of residual flow associated with AVPs.1
Most of such residual flow may be abolished with the use of
additional plugs, coils or gel foam.6.3. Recanalization
Recanalization after successful deployment with AVP is
extremely rare. A review estimated that there were only 5
reports of recanalization among more than 1200 AVP
placements.16.4. Device migration and embolization
Device migration and embolization following successful
deployment is also very rare in experienced hands. Self
expanding nature of the device with a good radial force pre-
vents migration even in a high flowing structure. The embol-
ized device may be retrieved percutaneously.6.5. Reconfiguration
An oversized device often lengthens significantly. However, a
few reports identified that nearly half of the AVPs reconfigure
to the original shape due to nitinol memory, but the clinical
importance of reconfiguration is not clear.21
i n d i a n h e a r t j o u rn a l 6 7 ( 2 0 1 5 ) 3 9 9e4 0 5 4057. Conclusions
Amplatzer vascular plugs are versatile occlusion devices that
are useful in a wide spectrum of clinical situations. The use of
AVP is associated with a very high technical success rate with
fewer complications. The indications for AVP are expanding.
Although initially used only for closing extra-cardiac high
flowing vascular structures, they now are used to close intra-
cardiac defects also. Adequate knowledge of various plugs is
essential for the appropriate use of these devices.Conflicts of interest
The author has none to declare.r e f e r e n c e s
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